Scholarlink

<p>All living cells have a sugar-coat that facilitates communication. Sialic acids cap mammalian glycans and are recognized by immune cells through sialic acid-binding immunoglobulin-like lectins (Siglecs) that regulate signaling by their cytoplasmic motifs. Inconsistent reports of Siglecs expression and sialoglycan recognition limit their therapeutic potential. Here we investigate 14 functional human Siglecs for their expression, glycan interactions and affinities. <i>SIGLEC</i> mRNA is broad in blood-derived monocytes and dendritic cells, restricted in natural-killer/B cells and absent in T cells, with similar Siglec-proteins expression in splenocytes. Binding to 114 glycans across 274 glycan microarrays, 220 splenocytes-assays and 132 cell-based arrays, reveal Siglecs functional relationships. Siglec−sialoglycan interactions are affected by sialic acid type (<i>N</i>-acetylneuraminic acid and <i>N</i>-glycolylneuraminic acid), 9-<i>O</i>-acetylation, linkage, sulfation, and carrier, are of varying affinities ( ~ 10 nM to µM/mM), and <i>cis</i> interactions are key regulatory features. This functional atlas enhances Siglecs potential as biomarkers and immunotherapy targets, switches or immune checkpoints for cancer and other diseases.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

An atlas of human siglecs integrates expression, affinity, and cis/trans sialoglycan recognition profiles

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月25日

查看全文
  • Shani Leviatan Ben-Arye,
  • Edward N. Schmidt,
  • Zeinab Jame-Chenarboo,
  • Claire Guetta-Oz,
  • Fahima Mozaneh,
  • Jaesoo Jung,
  • Kelli A. McCord,
  • Ronit Rosenfeld,
  • Kan Zhong,
  • Hongzhi Cao,
  • Hai Yu,
  • Xi Chen,
  • Lori J. West,
  • Matthew S. Macauley,
  • Vered Padler-Karavani

摘要

All living cells have a sugar-coat that facilitates communication. Sialic acids cap mammalian glycans and are recognized by immune cells through sialic acid-binding immunoglobulin-like lectins (Siglecs) that regulate signaling by their cytoplasmic motifs. Inconsistent reports of Siglecs expression and sialoglycan recognition limit their therapeutic potential. Here we investigate 14 functional human Siglecs for their expression, glycan interactions and affinities. SIGLEC mRNA is broad in blood-derived monocytes and dendritic cells, restricted in natural-killer/B cells and absent in T cells, with similar Siglec-proteins expression in splenocytes. Binding to 114 glycans across 274 glycan microarrays, 220 splenocytes-assays and 132 cell-based arrays, reveal Siglecs functional relationships. Siglec−sialoglycan interactions are affected by sialic acid type (N-acetylneuraminic acid and N-glycolylneuraminic acid), 9-O-acetylation, linkage, sulfation, and carrier, are of varying affinities ( ~ 10 nM to µM/mM), and cis interactions are key regulatory features. This functional atlas enhances Siglecs potential as biomarkers and immunotherapy targets, switches or immune checkpoints for cancer and other diseases.